CN1281375A - 增强透皮物剂流量的装置 - Google Patents
增强透皮物剂流量的装置 Download PDFInfo
- Publication number
- CN1281375A CN1281375A CN98811988A CN98811988A CN1281375A CN 1281375 A CN1281375 A CN 1281375A CN 98811988 A CN98811988 A CN 98811988A CN 98811988 A CN98811988 A CN 98811988A CN 1281375 A CN1281375 A CN 1281375A
- Authority
- CN
- China
- Prior art keywords
- supporting member
- body surface
- thin slice
- agent
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002708 enhancing effect Effects 0.000 title description 3
- 230000004907 flux Effects 0.000 title description 2
- 238000003860 storage Methods 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 23
- 230000005540 biological transmission Effects 0.000 claims description 22
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 238000007665 sagging Methods 0.000 claims description 5
- 238000012423 maintenance Methods 0.000 claims description 2
- 230000006835 compression Effects 0.000 claims 4
- 238000007906 compression Methods 0.000 claims 4
- 241001466460 Alveolata Species 0.000 claims 1
- 230000000881 depressing effect Effects 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 description 88
- 210000003491 skin Anatomy 0.000 description 81
- 238000005070 sampling Methods 0.000 description 31
- 239000000463 material Substances 0.000 description 17
- 239000010410 layer Substances 0.000 description 15
- 238000004891 communication Methods 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 239000011232 storage material Substances 0.000 description 7
- 230000037317 transdermal delivery Effects 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000012790 adhesive layer Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 230000000712 assembly Effects 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 210000000438 stratum basale Anatomy 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- -1 pottery Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005370 electroosmosis Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000004905 finger nail Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004031 devitrification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005685 electric field effect Effects 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 239000002117 illicit drug Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- ZACYQVZHFIYKMW-UHFFFAOYSA-N iridium titanium Chemical compound [Ti].[Ir] ZACYQVZHFIYKMW-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940100640 transdermal system Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B2010/008—Interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0046—Solid microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
- A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medicinal Preparation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrotherapy Devices (AREA)
Abstract
一种装置(3),它包括片件(6)和刚硬的支承件(15),该片件(6)具有多个微突(4),被用于穿刺皮肤;刚硬的支承件(15)与片件(6)接触,并延伸于整个片件(6)的宽度,用于将施加的力均匀地传递于整个片件(6)的长和宽,使微突(4)能重现地和准确地穿刺皮肤。
Description
技术领域
本发明涉及透皮物剂传递和采样。更具体的是,本发明涉及诸如肽和蛋白质的物剂经皮肤透皮传递,以及从机体透皮采样得到物剂,如葡萄糖,其它的机体分析物和一些滥用的物质如酒精和违禁药品。
技术背景
随着越来越多的医用肽和蛋白质能以量大、纯度高的形式为人所得,人们对透皮传递诸如肽和蛋白质的高分子量有利的物剂进入人体的兴趣不断上升。但肽和蛋白质的透皮传递仍面临着一些重大的问题。在许多场合下,这类物剂通过皮肤的传递速率或流量不足以产生理想的治疗效果,因为它们大体积/大分子量,导致不能由自然通途(孔,毛囊等)穿越皮肤。另外,多肽和蛋白质在穿越皮肤过程中,在到达靶细胞之前容易被降解。同样,水溶性小分子如盐的被动流动受到限制。
提高物剂透皮传递的一种方法基于电流通过体表的应用或称为“电转运”。“电转运”通常指有益的物剂,如物剂或物剂前体的通过诸如皮肤、粘膜、指甲等的体表。施加一个电位能诱导或增强物剂的转运,其导致施加电流来传递或增强物剂的传递。可以多种方式完成电转运物剂通过体表,一种广泛使用的电转运方式,离子电渗疗法,它涉及电诱导带电荷离子的转运。电渗透是另一种电转运方式,它涉及在电场的影响下带有物剂的溶液通过膜的迁移。还有一种电转运类型是电穿孔(E1ectroporation),它涉及物剂通过由高电压电脉冲在膜上形成的孔。多个例子中,可能多种方式以不同的程度同时发生。因此,本文中所述术语“电转运”给予可能的最广泛的解释,包括电诱导的或增强的至少一种带电或不带电荷的物剂或其混合物的转运,不管实际上转运物剂的特殊机制如何。这与被动的或无电相助的穿越皮肤传递有关,电转运递送通常能提高物剂的传递,尤其是大分子量的物剂(例如多肽)的传递速率。然而,在穿越皮肤过程中进一步提高穿越皮肤传递速率和减少多肽降解是非常令人想望的。
提高物剂穿越皮肤传递速率的一种方法包括用一种皮肤渗透增强剂预处理皮肤或协同有益的物剂传递。本文广泛应用的术语“渗透增强剂”,描述当应用于传递物剂的体表时能提高物剂流量的物质。其机制可能包括减少体表对物剂通过的电阻,提高体表的选择通透性和/或渗透性,产生通过体表的亲水途径和/或电转运期间减少物剂的降解(例如皮肤酶参与的降解)。
已作多个努力企图机械破坏皮肤以增强穿越皮肤的流量,如授予Ganderton等的美国专利3814097,授予Gross等的5279544,授予Lee等的5250023,授予Gerstel等的3964482,授予Kravitz等的美国专利Re 25637和PCT申请WO96/37155。尽管Gerstel揭示了其它形状的应用,但这些典型的装置通常利用管状或圆柱形结构穿刺皮肤的外层。这些参考文献中揭示的穿刺元件一般从薄的平面元件如垫片或金属薄片垂直伸展。该平面元件的柔韧性和穿刺元件的管状导致多个缺点。例如制造困难,当在该装置的顶端施压时该平面元件会弯曲,不能均匀地穿过皮肤,穿刺皮肤较差而导致电转运的透皮流量低,由于物剂集中流过少数通道而增加了刺激。
发明的叙述
本发明提供了适用于提高穿越皮肤流量的一种装置。该装置具有多个微突,这些微突均一并可靠地刺入体表(如皮肤)从而增强物剂的传递或采样。本发明的装置易大批生产,从而降低了成本。本装置能通过多个微突穿刺皮肤的角质层而形成管道,通过这些通道能输入(即传递)物质,例如物剂,或能提取(即采样)物质,例如机体分析物。本发明的主要优点是该装置通过其多个微突保证了均一的穿刺(即产生相同大小和深度的通道)。而且,本发明可重现地使不同病人被均一的穿刺。
一方面,本发明由刚硬的结构组成,该刚硬结构连接并延伸于整个有多个微突供穿刺皮肤的柔性的装置。这种刚硬结构把施加于结构顶端的力基本上均匀地传送到整个柔韧性装置上,由此产生微突的均匀移位。要达到这一目的就得使力加到带微突的易弯曲的该装置的能变形元件上时大大减少扩散。这刚硬的结构提供了确切可信的传递,把外加负荷传递给微突以便较容易地、完全和可重复地进行皮肤穿刺。用微突改善对皮肤的穿刺,因为这种坚固的结构特别有利于提高流量。这些微突的均匀分布的位移使所有的微突近乎全部刺入,结果产生相当数目的物剂通道和与皮肤的电连接(假如用电转运),以便物剂不断地和可重复地流过皮肤。
在本发明的这一个方面,该柔性的皮肤穿刺装置由相当薄的柔韧薄片组成,在使用中这块薄片适合于与被穿刺的体表基本平行地放置。薄片上具有多个开口,这些开口允许物剂在与这薄片相连的贮器(一般位于这薄片的远体表面)和通过微突刺入体表产生的孔之间通过。薄片也有多个微突(也被称之为微刃)从这薄片的近体表面几乎垂直地延伸出来。在本发明的这个方面,坚固的支承件结构连接并在整个薄片上延伸是为了增加结构的刚性和更均匀地分布力量于装置上,以达到更一致地迫使微突进入(即穿刺)体表。可任意选择地,虽然最好是该坚固的结构为物剂贮器形成一个空穴,该贮器能充满所包含/采样的物剂。
该发明的第二方面,柔性的皮肤穿刺装置由相当薄的柔韧薄片组成,该薄片具有一定空穴或空间的结构可容纳包含物剂或所收集物剂的贮器。使用中,与被穿刺的体表甚至垂直地安置薄片,如此能使薄片有一边接触体表,在该边具有从其延伸的多个微突。本发明的这一方面,刚硬的支承件结构连接和延伸越过整个薄片的远机体边缘,以便在那里增添结构上的刚性和更均匀地分布所加的力于装置上,以达到更一致地迫使这些微突进入(即穿刺)体表。
本发明的装置能用于物剂传递,物剂采样或两者兼用。尤其,本发明的装置能用于穿越皮肤的物剂传递,穿越皮肤的分析物采样或两者兼用。本发明使用的传递装置包含(但不限于)电转运装置,被动装置,渗透装置和加压驱动装置。本发明使用的采样装置包括(但不限于)反向电转运装置,被动装置,负压驱动装置和渗透装置。
本发明的这套装置能被重复使用,以保持体表的微伤口/微裂缝。这些微突产生的微伤口/微裂缝,在通过皮肤传递或采样的长时间内开放。病人或医疗技师都能很容易地做到这点,他们可定期地重复加压于该装置的远皮肤侧,使微突穿刺皮肤的角质层,克服由于机体的自然愈合过程导致的最初切口可能的封闭。
附图简述
在图中,相同的标号表示相同的构件
图1是沿图2中1-1线得到刚硬的支承件和皮肤穿刺元件的放大剖面图;
图2是图1中刚硬的支承件的顶视图;
图3是根据本发明的皮肤穿刺装置底部的一个实施方案的放大透视图,透明的联系介质从其流出;
图4,6和7是刚硬的支承件的其它实施方案的顶视图;
图5是刚硬的支承件和皮肤穿刺部件的另外的实施方案的分解透视图;
图8是依照本发明的支承件和皮肤穿刺部件另一种实施方案的侧面图;
图9是本发明的支承件的另一种实施方案的顶视图;
图10是本发明支承件的又一种实施方案的透视分解图;
图11是本发明支承件的另一种实施方案的截面透视分解图;
图12是依照本发明另一个实施方案,带有支承件的手持装置的透视图;
图13是依照本发明的一种实施方案的电转运物剂传递/采样系统的透视分解图;
图14是图13的电转运物剂传递/采样系统的底视图;
图15是图13的电转运物剂传递/采样系统的右视图;
图16是图13的电转运物剂传递/采样系统的后视图;
图17是图15的装配好的电转运物剂传递/采样系统沿线17-17的剖面图;
图18是依照本发明一种实施方案的被动物剂传递/采样系统的剖面图。
实行本发明的方法
现在回头详细说明这些附图,在图1中显示的本发明的装置2包括皮肤穿刺片件6和支承件15。使用装置2,能增强物剂的穿越皮肤传递或采样。本案中的术语“物质”、“物剂”和“药物”可互换使用,广泛地包括人类和灵长类等哺乳动物,鸟类,有价值的家养,运动场或农场动物,或供实验用的动物,诸如大小白鼠、豚鼠等产生局部或全身效应的生理或药理活性物质。这些术语也包括象葡萄糖这样的物质,在组织中,间质液和/或血液中发现的其它分析物质,乙醇,合法的物质和违禁的物剂等,这些物质能够通过皮肤采样。
物剂穿越皮肤流动(例如传递物剂和采样分析)的主要屏障是最外层(即角质层)。表皮内层一般包含二层,通常称为颗粒层、表皮生发层和生发层。要通过颗粒层、表皮生发层和生发层转运或吸收一种物剂,应基本上没有或者没有阻力。装置2包括刚硬的支承件15和柔软的片件6(见图3,图中的装置2为显示其微突而处倒置位置),它具有多个向外延伸的微突4。装置2被压到皮肤的一个区域,通过这里物剂被透皮传递或采样。微突4在皮肤上形成裂缝并至少能穿过角质层,这样,物剂很少有阻碍或没有阻碍地通过皮肤而被传递。典型情况下,微突穿刺皮肤可深达500μm深度,一般也可达50至300μm。为了穿刺皮肤或体表,微突4可以是微刀片状(图1和3)、针状(未显示)或其它各种形状。当用压力加到支承件15的顶部时,微突4穿刺表皮的角质层,以增加物剂通过体表给药或采样。本案中所用的术语“体表”通常指人或动物的皮肤、粘膜和指甲,和植物的外表面。微突4穿刺体表使物剂从系统很好地传导进入体表,反之亦然。
在图1-3中所显示的实施方案中,片件6与多个开口8构成一体,每个开口8至少有一个微突4沿着其边缘。微突4在角质层中割开一个微小裂缝,从而增加了从由多个空穴7容纳的物剂贮器27透皮释放的物剂,或收集在由多个空穴7容纳的收集贮器27里物剂的透皮流量。
片件6可以由金属、硅或塑料构成,以金属如不锈钢和钛为佳。由于片件6相当的薄,因而是柔软的和易弯曲的,例如当片件6由金属如不锈钢或钛构成,它将只有大约5μm至10μm厚度,一般大约为25-50μm。
依照本发明,比片件6更坚硬的刚硬结构的支承件15被安置在整个片件6上(图1和2)。当装置2被用于体表,并施加下压力(即直接朝体表穿刺)引起微突4穿刺体表时,支承件15防止片件6变形或弯曲。支承件15应当足够刚硬,使在手工用手指或手把装置2对着皮肤压下时,其下垂低于300μm,低于50μm为更佳。支承件15可以是各种不同形状,例如,但不限于,图1,2,4-8和13中所显示的实施方案。在图1和2中显示的实施方案中,支承件15是刚硬的结构,它形成了延伸跨越整个支承件的厚度的多个空穴7,空穴7共同容纳贮器27(图1)供被释放的物剂或被采集来的物剂放置。在空穴7之间是多个支承件或横梁5,它们与整个片件6连接并沿整个片件6的长或宽延伸。横梁5将加于装置3顶部的力均匀地传递到整个片件6,因而每个微突4移位(进入皮肤)的距离相同。当使用透皮电转运装置时,片件6和/或支承件15被最佳的惊人地与电转运装置的电极分开或者被绝缘,这是为了避免物剂贮器短路。这可以用非导电材料,电绝缘材料或在片件6和/或支承件15上加涂层而达到目的。
更可取的是支承件15也有低的可压缩性,在手指或手把装置对着皮肤加压的过程中,最理想的支承件15被压缩的距离少于200μm,更好的是少于50μm。最好是在用手指或手把装置压向皮肤的过程中,支承件15显示的可压缩性低于约250μm并兼有柔性。
支承件15可以用具有前述高度刚性的任何材料制成,优选的是还有前面提到的压缩性低。合适的材料包括金属、合金、陶瓷、玻璃、刚性塑料和加强材料(例如碳纤维强化材料)。
图2和图4-13说明了各种实施方案的支承件。在图2,4-7和13中所显示的实施方案,支承件15被边缘的(例如环状的)围壁53构成,它至少有一个横梁5延伸在整个支承件15上,这样就产生多个容纳物剂贮器的空穴7,并将施加的力充分均匀地分散到整个片件6上(即不使片件6弯曲)。图4,5,6和13中的横梁通常沿对角线延伸于由支承件15的外壁所限定的整个空间。本案所用的对角线,表示与下述横梁不同的实施方案(即不指横梁连接直线形的两个不相邻的顶点,或者通过多面体两条不相邻的边),正如这些图中所示的实施方案的情况。如图中所见,横梁包括倾斜的(图6)和不倾斜的(图7)横梁以及蜂窝状的结构(图2)。横梁的数目依赖于各种因素,例如片件6和支承件15的相对的结构完整性或柔性,整个支承件15的距离,物剂贮器接触皮肤面积的大小,以及物剂贮器的容积。一般,当使用非常薄的金属制成片件6时,在支承件15上相邻横梁5之间的最大距离,与片件6上的相邻微突4之间的距离相比,将不大于约4倍,而最好不大于约2倍。图7描述支承件15可由经多个横梁5与外环壁53连接的多个内环壁55构成。
图5描述片件6可供选择的实施方案,其微突4从薄的片状部件6的机体接触边缘49向外延伸。在这个实施方案中,使用过程中,片件6的平面大致沿与体表垂直的方向伸展。片件6具有螺旋状形态,它限定了空穴51供放置含有物剂或接受物剂的贮器(图5未示)。片件6的形状也可以是卷绕形、折叠形(未显示)和曲线形(未显示)以及其它形状,通常从它的平面状态沿着它的长度形成具有多个空穴51的结构。较好的实施方案是空穴51与支承件15的空穴7连通。
在图1和5中显示出与片件6的远皮肤侧面/边缘接触的支承件15的表面通常是平坦的(即成平面)。然而,与片件6连接的支承件15的表面最好具有凸面或曲线形(例如圆柱形状)表面54(如图8所示)。凸面或圆柱形表面54的曲率半径最好大于约5cm,大于约10cm更佳。
图9描述了支承件15的另外的实施方案,在该实施方案中,支承件15由多个具有波形结构的长条组成,并且均对片件6的平面垂直定向。片件6的结构与图3相同,其上有开口8,并与微突4联系(图9未示)。波形长条91,93在其连接点95处最好被固定在一起,如薄片91,93由金属或塑料制成时用焊接固定。相邻的长条91,93的波形结构形成空穴93,在这中间容纳适当的贮器材料。这样,长条91和93的高度将部分地由装入空穴97的贮器材料的厚度的支配。
图10,又描述了支承件15的另一种实施方案,该实施方案中支承件15由波形薄片101构成,波形薄片101加工成与片件6的远皮肤侧面接触。如有必要,覆盖波形薄片101远皮肤侧面的覆盖薄片(图10未示),或沿着波形薄片101侧边的轨道(图10未示)能提供额外的刚性并在向薄片101的远皮肤侧面施力时,阻止薄片101沿波纹折叠弯曲或折叠的任何趋势。在波形薄片101上可以有多个开口,因此,物剂通过波形薄片101的流动成为可能。开口的大小和数量(图10未示)不是决定性的,只要波形薄片101的结构完整性和刚性不受损害即可。这将有可能在与薄片101的远皮肤侧面相邻的空穴104安置额外的贮器材料。如在其它实施方案中一样,贮器材料能被装进波形物和下面的片件6之间形成的空穴103中(图10未示)。
图11揭示一种波纹片101可选择的实施方案,其波纹折叠不完全相互平行。与图10的装置相似,为了提高波纹片101结构的刚性,如有必要,图11装置也在波形片101的远皮肤侧面上附有覆盖薄片,或者选用围绕波形片101的环状轨道。比图10更进一步,可如图11的装置为让物剂通过那里传递,在波形片101上存在了多个开口(图11未示),这种开口有可能利用空穴104来容纳物剂贮器材料。
图1-2,4-7,9-11和13中描述的支承件15的共同特征是支承件15包含一些空穴(如空穴7,97和103),贮器材料能被装载入这些空穴内。另一方面,片件6的某些实施方案如图5中所示,有其自身的空穴51容纳贮器材料。在这种情况下,以及在把含有物剂/采样的贮器放在预处理的皮肤上之前将这片件6应用于皮肤作为预处理的情况下,用不着把该支承件15完整地作为片件6的一个部件,或者将它固定附着在这片件6上。
图12描述支承件115,它是用于把片件6压向皮肤的手持装置112的头部,该头部115由金属板构成,板有足够的厚度(如0.5cm或更厚)使其具有足够的刚性。支承件115与装置112用螺纹113相连。以使微突4刺穿皮肤,表面111对着片件6压下。表面111可有凸曲率(如图12所示和联系图8的讨论)也可只是平坦表面(即平面)。任选的是,为了使支承件115以预定的力量压紧片件6的远皮肤侧,装置112可以由弹簧支承。
虽然已经初步描述了本发明的支承件15借助于片件6和微突4对身体组织(如皮肤)的初次应用与穿刺,但是,本领域技术人员将意识到该刚硬的支承件15也可用于重复使用片件6(即以后的使用)和接着的微突4穿刺,其部位可以是与第一次相同的体表处或在新的体表部位。用微突4在原来的体表位置上(即微突4初次刺破的体表位置)再次刺破皮肤,对于使微突4产生的微切口/微裂缝保持开放是有益的。这样,穿越皮肤的物剂流量能继续不受阻碍。穿越皮肤的物剂传递/采样装置,正如图13-18显示的,在穿越皮肤传递或采样过程中,一般适合粘附于皮肤。在微突4初次产生通过角质层的微切口/微裂缝之后,皮肤立即开始愈合过程,最后,微裂缝将由于愈合过程继续而关闭。因此,为了保持微裂缝开放和使得穿越皮肤的物剂流量不受阻碍,使用手指对着皮肤再使用片件是令人满意的。这能用本发明的支承件结构很容易地完成。当穿越皮肤传递/采样装置被粘附到皮肤时,为了引起微突4再次刺破角质层,病人或技师可简单地定时重复用手指或手对装置的远皮肤侧面施压。
微突或微刃4通常由一片材料构成,而且对于至少穿剌皮肤的角质层是足够尖锐,有足够长度。在一个实施方案中,微突4和片件6对物剂通过基本上是不渗透的或不能渗透的。每个微突的宽度可以是任何宽度范围。在一批微突插入以后,微突和体表的相交处的微突宽度一般至少约为25mm。所需要的刀刃长度由被穿刺的体表的差异确定,至少相当于角质层的天然厚度,因为本发明的主要特征之一是微突至少要穿过角质层进入表皮层。通常,微突要有一定的长度和结构,要使其穿刺的深度达到大约25-400mm,应用最多的穿刺深度在大约50-200mm之间。微突4能够倾斜(即能形成一角度)使边缘64(图3)进一步减少按压微突进入皮肤组织所需要的穿刺力。每个微突4的前沿都处于适合穿刺皮肤的相同角度或不同角度。或者,每个微突的前沿可以形成曲线,例如形成凸形或凹形或被分成任何数目的倾斜片断,例如第一段比较垂直,第二段与垂直成圈套的角度。
如同WO 97/48440中阐明的,先用照相制板术,再用化学蚀刻术,然后用微冲压术能生产片件6,在此引证并包括这些揭示。图5所描述的片件6的具体实施方案需要使平面的片件6形成所期望的空穴形状的附加步骤(即螺旋形,蛇形,同心圆等等)。利用已知的金属片弯曲,辊压,折叠和/或成形的技术能达到目的。
通常,冲压以后微突4与片件6的表面48成大约90度的角(图3),但是能安排它们从垂直位置成向前和向后的任何角度以利于穿刺角质层。
从具有足够强度和制造微突能力的材料,例如玻璃,陶瓷,坚硬的聚合物,加强的(如碳纤维加强固)聚合物、金属和金属合金,制造片件6和微突4。金属和金属合金的例子包括,但不限于不锈钢,铁,钢,锡,锌,铜,金,铂,铝,锗,锆,钛和钛合金。每一片件和每个微突都可具有一薄层金、铂、铱钛或铑镀层。玻璃的例子包括二氧化硅和Corning公司(美国纽约)供应的“PHOTOCERAM”这样的反玻璃化的玻璃。聚合物的例子包括,但不限于聚苯乙烯,聚甲基丙烯酸甲酯,聚丙烯,聚乙烯,“Bakelire”(“酚醛塑料”),醋酸纤维素,乙基纤维素,苯乙烯/丙烯腈共聚物,苯乙烯/丁二烯共聚物,丙烯腈/丁二烯/苯乙烯(ABS)共聚物,聚氯乙烯和丙烯酸共聚物,它包括聚甲基丙烯酸酯的聚丙烯酸酯。
片件6的任何实施方案的微突4和开口8的数目,随所期望的流速,被采样或递送的物剂,所用的传递或采样的装置(即电转运,被动扩散,渗透,压力驱动等)和本领域普通技术人员会了解的其它因素而有差异。一般,单位面积微突数(即微刃密度)越大,则皮肤内物剂流量(每个微裂缝)越不集中,因为有较多通过皮肤的通道。因此,单位面积微突数较少会使通过皮肤的物剂的传递更集中在较少的通道内。皮肤通道内较高浓度的物剂可导致较高发生率和/或严重性的皮肤反应(例如刺激性)。因此,较大的微刃密度能减少皮肤反应的发生率和/或严重性。
可预先安置一种可供选择的联系介质(未显示)在具有如WO 98/28037所说的图1-3中所显示的该结构的片件6的皮肤接触面48上,现引证其揭示内容包括于此。这种联系介质,如果使用,是作为物剂的管道,作为包含物剂的贮器或收集物剂的贮器与皮肤之间的桥梁而起作用,由此允许物剂无阻碍地经那里被传递。
可与本发明一起使用的一种穿越皮肤传递/采样的装置,依赖于通过体表的电流或“电转运”的应用。在本领域中的那些工作将正确地评价本发明能与各种电转运系统联合使用,因为在这方面本发明不局限于任何方式。电转运系统的例子可以参考Theeuwes等的US专利5147296,Theeuwes等的5080646,Theeuews等的5169382,Phipps等的5423739,Haak等的5385543,Gyory等的5310404和Gyory等的5169383,其中任何被揭示的电转运系统都能用于本发明。
图13-17阐明一代表性的电转运传递/采样装置10,按照本发明,该装置10可以与支承件15和皮肤穿刺装置2合用。装置10包含一个上罩16,一个电路板组件18,一个下罩20,供体电极22,反电极24,供体贮器27,反贮器28和与皮肤相容的胶合剂30。上罩16有侧翼31,该侧翼协助保持装置10在病人皮肤上。印刷电路板组件18包含一个与分立组件40和电池(组)32匹配的集成电路19。借助通过开口13a和13b的支柱33(图17中仅显示一个)把电路板组件18附着在罩子16上,为了把电路板组件18热固定在罩16上,支柱的末端被加热/熔化。借助粘合层30把下罩20附着在上罩16上,粘合层30的上表面34既附着于下罩20又附着于包括侧翼31的底表面的上罩16。在电路板组件置18下表面上显示出(部分地)钮扣小电池32。根据需要也可应用其它类型的电池启动装置10。装置10一般由电池32,电子电路系统19,40,电极22,24,反贮器28,安置供体贮器27的支承件15和皮肤穿刺装置2组成。所有这些部件被合并成整套装在一起的统一体。下罩20包括电极22,24和贮器27,28。电路板组件18的输出(图13未示)用导电胶带42,42’通过下罩20中形成的凹陷25,25’的开口23,23’与电极24和22进行电连接。电极22和24’依次与贮器27和28的顶端面44’,44直接进行机械和电相接。反贮器28的底面46通过粘合层30的开口29与病人的皮肤接触。供体贮器27的底面46’通过皮肤穿刺装置2中的多个开口8与病人的皮肤接触,如图1所示。供体贮器27中的物剂一般是溶液状态,最好是水溶液,该水溶液可包含于诸如海绵的固体固体基质中,海绵是亲水性聚合物基质(例如水凝胶),它允许物剂通过、自由流动。贮器基质充满开口8而使物剂贮器与体表相接触,如图1所示。如上述讨论,可把一层联系介质放在片件6的近皮肤侧面,微刃4通过那里。可任意选择的联系介质提供了供体贮器27和皮肤之间更均一的物剂流动通道。通常,因为扩散或因为贮器和联系介质有相同的物质,物剂最初存在于贮器和联系介质内。
装置10借助四周的粘合层30(粘合层有上粘合面34和与机体接触的粘合面36)粘附于病人的体表(例如皮肤),且可任意将这里讨论的任何实施方式中装置2上的元件固定。而且,为了帮助维持界面与皮肤的接触,联系介质65可任意选择有点粘的或是粘的。粘合面36覆盖了除装置2和反电极贮器28所占地位以外装置10的整个下侧面。粘合面36具有粘合性,该性质保证装置10在使用者正常活动期间保持在机体上,然而,在预定的(如24小时)使用期以后允许适当地移动。上粘合面34粘附在下罩20上,并且将电极和物剂贮器保持在罩的凹陷25,25’之内并维持装置2与下罩20相连,下罩20与上罩16相连。
在物剂传递/采样装置的一个实施方式中,为了在装置不用时保持粘合层30的完整性,在装置10上有一剥离层衬垫(未示)。使用时,在装置用于皮肤之前剥去剥离层。装置10也有一个按钮开关12,当按下开关钮时,装置10开动了,通过LED14变亮可使使用者知道。在预定的传递时间内,由电转运传递物剂通过病人的皮肤(如臂上)。
本发明的其它实施方式中,把支承件15预先安排在部件6的顶面上,使用被动的透皮传递或采样装置。本领域的技术人员将能了解,本发明能与各种被动的透皮系统连用,因为本发明在这方面并不受限制。例如被动系统的例子,可能必须参考,但并不限于Campbell等的US专利4379454,Gale等的4588580,Gampbell等的4832953),Gale等的4698062,Campbell等的4867982和Hunt等的5268209,本发明可与这些专利中揭示的任何系统合用。图18中阐明了被动透皮传递/采样装置的一个例子。具有装在其外环形壁53内的片件6边缘的支承件15被装在能被应用于体表的泡沫衬垫或嵌条57中。片件6的边缘不需要被装在外环形壁内,因为如前面实施方式所叙,片件6能被连接在支承件15上。延伸在整个环形壁53和横梁5上的是一刚硬的顶盖59。顶盖59非常坚硬,以致当力量向它施加时不变形,并能更均匀地传递所加的力以及更均匀地传递整个片件6的长和宽上,使微突4位移。虽然并不要求,但最好被动传递/采样装置在泡沫衬垫57接触机体的面上,四周有粘合剂,在部件2接触机体的面上有一粘合的界面凝胶(未示)。
本领域中的人员将会了解,本发明也能与各种渗透和压力驱动系统结合使用,因为本发明在这方面不限于特殊装置。渗透和压力驱动装置的例子,可能必须参考Eckenhoff的US专利4340480,Theeuwes等的4655766,Eckenhoff的475365l,Gross等的5279544,Theeuwes的4655766,Gross等的5242406,和Eckenhoff的4753651,其中任一个都可与本发明结合使用。
本发明对通常通过体表和膜(包括皮肤)传递各类药物是有用的。一般,它包括所有治疗领域中的药物。本发明也用于天然存在的,化学合成的或重组生产的蛋白质,肽类及其片段的穿越皮肤传递。另外,本发明可另外用来配合疫苗,包括寡核苷酸类药物,聚核苷酸类药物的核苷酸类药物和基因的传递。这些物质一般分子量至少有300道尔顿左右,有的分子量至少大约300至40,000道尔顿。如以上提及的,本发明装置2也可与采样装置联用,包括,但不限于,逆向电转运(即在不带电荷的物质如葡萄糖采样的情况下,反向离子电渗和/或电渗透),渗透和反向被动扩散。例如可以参考Eckenhoff等的US专利4756314,Schoendorfer的5438984,Glikfeld等的5279543和Guy等的5362307。
本领域中的一般技术人员将会了解,本发明可以其它特殊的形式实施,而不偏离它的精神和基本特征。因此这里揭示的实施方案,应该认为在所有方面都是说明性而不具有限制性。由所附的权利要求书而不是前面的阐述表明本发明的范围,这里意思是包括它的等价物的含义和范围中所有的变化。
Claims (35)
1.一种用于通过体表导入或取出物剂的装置(2),包括有多个微突(4)的部件(16),这些微突从部件(16)的近体表侧部件(48)延伸出来,所述装置(2)的特征在于:
结构支承件(15)与部件(6)的至少一部分接触并延伸跨越所述的部分,支承件(15)的刚性比部件(6)大。
2.如权利要求1所述的装置,其中支承件(15)对垂直于体表的施加力,其刚性比部件(6)的大。
3.如权利要求1所述的装置,其中支承件(15)在人工用手指或手对皮肤压下装置(2)的情况下具足够刚性,下垂小于300μm。
4.如权利要求3所述的装置,其中支承件(15)在所述按压情况下下垂小于50μm。
5.如权利要求1所述的装置,其中支承件(15)在人工用手指或手对着皮肤按压装置(2)的情况下,支承件基本上是不可压缩的,压缩度小于250μm。
6.如权利要求5所述的装置,其中支承件(15)在所述按压情况下压缩小于50μm。
7.如权利要求1所述的装置,其中部件(6)包括一薄片,使用中薄片与体表近似平行,薄片上有多个开口(8)和从薄片的近机体表面(48)延伸出来的多个微突(4),所述的微突(4)适合于穿刺体表。
8.如权利要求1所述的装置,其中支承件结构(15)限定了供容纳包含物剂或收集物剂的贮器的空穴(7)。
9.如权利要求7所述的装置,其中贮器与薄片上的开口(8)一起是物剂传递途径。
10.如权利要求1所述的装置,其中支承件(15)包括周边部件(53)和多个横梁(5)。
11.如权利要求1所述的装置,其中支承件(15)有一蜂窝状结构。
12.如权利要求1所述的装置,其中支承件(15)包含波形薄片(101)。
13.如权利要求1所述的装置,其中支承件(15)有一与部件(6)接触的弯曲面(54)。
14.如权利要求13所述的装置,其中弯曲面(54)具有选自凸面和圆柱形面的形状。
15.如权利要求7所述的装置,其中支承件(15)包含多个波形条(91,93),这些波形条与片件(6)垂直排列。
16.如权利要求1所述的装置,其中片件(6)的厚度在100μm以下。
17.如权利要求16所述的装置,其中片件(6)由金属组成。
18.如权利要求1所述的装置,其中部件(6)包括薄片,该薄片有多个微突从片件(6)的近体表边缘(49)延伸出来以穿刺体表,薄片(6)在使用时与体表近似垂直,而近体表边缘(49)有接触体表的微突(4)。
19.如权利要求18的所述的装置,其中薄片具有一个为了容纳包含物剂或收集物剂的贮器而限定空穴(51)的结构。
20.如权利要求18所述的装置,其中支承件(15)与该薄片的第二边缘相连,薄片的第二边缘与具有微突(4)的近体表边缘(49)相对。
21.一种使经过体表的物剂传递通道保持开通的方法,所述的体表上具有位于其邻近的权利要求1所述的装置(2),该方法包括向所述的装置(2)定期地重复施加指向体表的力。
22.如权利要求21所述的装置,其中所述的重复施加引起所述的微突(4)重复穿刺体表。
23.如权利要求21所述的方法,其中所述的力由人工施加。
24.如权利要求21所述的方法,其中支承件(15)包括一环状部件(53)。
25.如权利要求24所述的方法,其中环状部件(53)是一个具有对角线横梁(5)的圆形、方形或长方形环状部件。
26.如权利要求21所述的方法,其中支承件结构(15)具有多个横梁(5)。
27.如权利要求26所述的方法,其中多个横梁(5)一般在支承件结构(15)的中心交叉。
28.如权利要求21所述的方法,其中支承件结构包括:
一个外环形部件(53);
一个直径小于外环形部件(53)的内环形部件(55);和
横梁(5)把内环形部件(55)和外环形部件(53)连接在一起。
29.如权利要求21所述的方法,其中对于垂直施加于体表的力,支承件(15)的刚性比部件(6)的大。
30.如权利要求21所述的方法,其中支承件(15)在人工用手指或手对着皮肤按压装置(2)的情况下有足够的刚性使下垂不超过300μm。
31.如权利要求30所述的方法,其中支承件(15)在所述按压下下垂不超过50μm
32.如权利要求21所述的方法,其中支承件(15)在人工应用手指或手对着皮肤按压装置的情况下,该支承件有足够的不可压缩性,使压缩小于250μm。
33.如权利要求32所述的方法,其中该支承件在所述按压下压缩小于50μm。
34.如权利要求21所述的方法,其中部件(6)包括一薄片,薄片在使用时几乎与体表平行。薄片有多个开口(8)和从薄片的近机体表面(48)伸出的多个微突(4),所述微突(4)适合于刺穿体表。
35.如权利要求21所述的方法,其中支承件结构(15)限定一空穴。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6933997P | 1997-12-11 | 1997-12-11 | |
US60/069,339 | 1997-12-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1281375A true CN1281375A (zh) | 2001-01-24 |
CN1206004C CN1206004C (zh) | 2005-06-15 |
Family
ID=22088308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB988119889A Expired - Fee Related CN1206004C (zh) | 1997-12-11 | 1998-12-09 | 增强透皮物剂流量的装置 |
Country Status (13)
Country | Link |
---|---|
US (2) | US6322808B1 (zh) |
EP (1) | EP1037687B8 (zh) |
JP (1) | JP2001525227A (zh) |
KR (1) | KR100557261B1 (zh) |
CN (1) | CN1206004C (zh) |
AT (1) | ATE406935T1 (zh) |
AU (1) | AU757230B2 (zh) |
CA (1) | CA2313700C (zh) |
DE (1) | DE69839969D1 (zh) |
DK (1) | DK1037687T3 (zh) |
ES (1) | ES2314995T3 (zh) |
PT (1) | PT1037687E (zh) |
WO (1) | WO1999029298A2 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103908240A (zh) * | 2014-04-03 | 2014-07-09 | 汪成 | 一种人体电信号监测用电极片 |
US8932539B2 (en) | 2009-03-25 | 2015-01-13 | Pathway Genomics Corporation | Saliva sample collection systems |
CN110063836A (zh) * | 2014-04-23 | 2019-07-30 | 塞罗斯医学有限责任公司 | 真空辅助药物递送装置 |
Families Citing this family (240)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2195151T3 (es) * | 1996-06-18 | 2003-12-01 | Alza Corp | Dispositivo de mejora de aporte o de muestreo de agentes transdermicos. |
US6918901B1 (en) * | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
KR100557261B1 (ko) | 1997-12-11 | 2006-03-07 | 알자 코포레이션 | 경피성 작용제 유동률을 증진시키기 위한 장치 |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6379324B1 (en) | 1999-06-09 | 2002-04-30 | The Procter & Gamble Company | Intracutaneous microneedle array apparatus |
US6312612B1 (en) | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
US6565532B1 (en) | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
US6607513B1 (en) * | 2000-06-08 | 2003-08-19 | Becton, Dickinson And Company | Device for withdrawing or administering a substance and method of manufacturing a device |
US9717451B2 (en) | 2000-06-08 | 2017-08-01 | Becton, Dickinson And Company | Device for withdrawing or administering a substance and method of manufacturing a device |
US6540675B2 (en) | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
US6440096B1 (en) * | 2000-07-14 | 2002-08-27 | Becton, Dickinson And Co. | Microdevice and method of manufacturing a microdevice |
CN100421653C (zh) | 2000-09-08 | 2008-10-01 | 阿尔扎公司 | 通过抑制通道关闭来抑制药物透皮通量减少的方法 |
JP4659332B2 (ja) * | 2000-10-13 | 2011-03-30 | アルザ・コーポレーシヨン | 微小突起を用いて皮膚を穿孔するための装置および方法 |
RU2278623C2 (ru) * | 2000-10-13 | 2006-06-27 | Алза Корпорейшн | Держатель микровыступающего элемента для силового аппликатора |
US7419481B2 (en) * | 2000-10-13 | 2008-09-02 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
US7828827B2 (en) | 2002-05-24 | 2010-11-09 | Corium International, Inc. | Method of exfoliation of skin using closely-packed microstructures |
US7131987B2 (en) | 2000-10-16 | 2006-11-07 | Corium International, Inc. | Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation |
US7108681B2 (en) | 2000-10-16 | 2006-09-19 | Corium International, Inc. | Microstructures for delivering a composition cutaneously to skin |
JP4659336B2 (ja) * | 2000-10-26 | 2011-03-30 | アルザ・コーポレーシヨン | 被覆された微細突出物を有する経皮的薬剤配達装置 |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6663820B2 (en) | 2001-03-14 | 2003-12-16 | The Procter & Gamble Company | Method of manufacturing microneedle structures using soft lithography and photolithography |
US6855372B2 (en) | 2001-03-16 | 2005-02-15 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
US20040185055A1 (en) | 2001-03-19 | 2004-09-23 | Glenn Gregory M | Transcutaneous immunostimulation |
BR0209046A (pt) * | 2001-04-20 | 2004-11-09 | Alza Corp | Disposição de microprojeção que possui um agente benéfico contendo revestimento |
US20020193729A1 (en) * | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
US6591124B2 (en) | 2001-05-11 | 2003-07-08 | The Procter & Gamble Company | Portable interstitial fluid monitoring system |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
WO2002100460A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Electric lancet actuator |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
JP4209767B2 (ja) | 2001-06-12 | 2009-01-14 | ペリカン テクノロジーズ インコーポレイテッド | 皮膚の性状の一時的変化に対する適応手段を備えた自動最適化形切開器具 |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US6943267B1 (en) | 2001-08-24 | 2005-09-13 | Utah State University | Thiophosphonate inhibitors of phosphatase enzymes and metallophosphatases |
US6830562B2 (en) | 2001-09-27 | 2004-12-14 | Unomedical A/S | Injector device for placing a subcutaneous infusion set |
US20030135166A1 (en) * | 2001-09-28 | 2003-07-17 | Gonnelli Robert R. | Switchable microneedle arrays and systems and methods relating to same |
US6689100B2 (en) | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
WO2003048031A2 (en) * | 2001-11-30 | 2003-06-12 | Alza Corporation | Methods and apparatuses for forming microprojection arrays |
HUP0402605A2 (hu) * | 2001-12-20 | 2005-06-28 | Alza Corporation | Eszköz mikroszkopikus bemetszések ejtésére állat bőrszövetén |
US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US7047070B2 (en) * | 2002-04-02 | 2006-05-16 | Becton, Dickinson And Company | Valved intradermal delivery device and method of intradermally delivering a substance to a patient |
US7115108B2 (en) * | 2002-04-02 | 2006-10-03 | Becton, Dickinson And Company | Method and device for intradermally delivering a substance |
US6780171B2 (en) | 2002-04-02 | 2004-08-24 | Becton, Dickinson And Company | Intradermal delivery device |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US6945952B2 (en) * | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
EP1523367A1 (en) | 2002-07-19 | 2005-04-20 | 3M Innovative Properties Company | Microneedle devices and microneedle delivery apparatus |
JP4460451B2 (ja) * | 2002-08-29 | 2010-05-12 | ベクトン・ディキンソン・アンド・カンパニー | 回転マイクロ剥離面による物質送達 |
US20040051019A1 (en) | 2002-09-02 | 2004-03-18 | Mogensen Lasse Wesseltoft | Apparatus for and a method of adjusting the length of an infusion tube |
US8062573B2 (en) * | 2002-09-16 | 2011-11-22 | Theraject, Inc. | Solid micro-perforators and methods of use |
AU2003275301A1 (en) * | 2002-09-30 | 2004-04-23 | Alza Corporation | Drug delivery device having coated microprojections incorporating vasoconstrictors |
DK200201823A (da) | 2002-11-26 | 2004-05-27 | Maersk Medical As | Forbindelsesstykke for en slangeforbindelse |
US7388079B2 (en) * | 2002-11-27 | 2008-06-17 | The Regents Of The University Of California | Delivery of pharmaceutical agents via the human insulin receptor |
AR042815A1 (es) * | 2002-12-26 | 2005-07-06 | Alza Corp | Dispositivo de suministro de agente activo que tiene miembros compuestos |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US7578954B2 (en) | 2003-02-24 | 2009-08-25 | Corium International, Inc. | Method for manufacturing microstructures having multiple microelements with through-holes |
US7052652B2 (en) | 2003-03-24 | 2006-05-30 | Rosedale Medical, Inc. | Analyte concentration detection devices and methods |
WO2004107975A2 (en) | 2003-05-30 | 2004-12-16 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US20050123507A1 (en) * | 2003-06-30 | 2005-06-09 | Mahmoud Ameri | Formulations for coated microprojections having controlled solubility |
CA2530531A1 (en) * | 2003-06-30 | 2005-01-20 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
TW200513280A (en) * | 2003-07-02 | 2005-04-16 | Alza Corp | Microprojection array immunization patch and method |
MXPA06001409A (es) * | 2003-08-04 | 2006-08-25 | Johnson & Johnson | Metodo y dispositivo para mejorar flujo de agente trasdermico. |
AU2004268616B2 (en) | 2003-08-25 | 2010-10-07 | 3M Innovative Properties Company | Delivery of immune response modifier compounds |
US8353861B2 (en) * | 2003-09-18 | 2013-01-15 | Texmac, Inc. | Applicator for applying functional substances into human skin |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
CA2543084A1 (en) * | 2003-10-24 | 2005-05-12 | Alza Corporation | Apparatus and method for enhancing transdermal drug delivery |
AU2004285484A1 (en) * | 2003-10-24 | 2005-05-12 | Alza Corporation | Pretreatment method and system for enhancing transdermal drug delivery |
BRPI0415986A (pt) * | 2003-10-28 | 2007-01-23 | Alza Corp | método e aparelho para reduzir a incidência do uso de tabaco |
EP1680154B1 (en) * | 2003-10-31 | 2012-01-04 | ALZA Corporation | Self-actuating applicator for microprojection array |
MXPA06005509A (es) * | 2003-11-13 | 2007-05-23 | Johnson & Johnson | Sistema y metodo para distribucion transdermica. |
US20070083151A1 (en) * | 2003-12-29 | 2007-04-12 | Carter Chad J | Medical devices and kits including same |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1718452A1 (en) * | 2004-02-23 | 2006-11-08 | 3M Innovative Properties Company | Method of molding for microneedle arrays |
EP1737357B1 (en) | 2004-03-24 | 2019-12-11 | Corium, Inc. | Transdermal delivery device |
ES2323793T3 (es) | 2004-03-26 | 2009-07-24 | Unomedical A/S | Conjunto de infusion. |
AU2005235990A1 (en) * | 2004-04-13 | 2005-11-03 | Alza Corporation | Apparatus and method for transdermal delivery of multiple vaccines |
US7857767B2 (en) | 2004-04-19 | 2010-12-28 | Invention Science Fund I, Llc | Lumen-traveling device |
US8024036B2 (en) | 2007-03-19 | 2011-09-20 | The Invention Science Fund I, Llc | Lumen-traveling biological interface device and method of use |
US7998060B2 (en) | 2004-04-19 | 2011-08-16 | The Invention Science Fund I, Llc | Lumen-traveling delivery device |
US8512219B2 (en) | 2004-04-19 | 2013-08-20 | The Invention Science Fund I, Llc | Bioelectromagnetic interface system |
US7850676B2 (en) | 2004-04-19 | 2010-12-14 | The Invention Science Fund I, Llc | System with a reservoir for perfusion management |
US8337482B2 (en) | 2004-04-19 | 2012-12-25 | The Invention Science Fund I, Llc | System for perfusion management |
US8361013B2 (en) | 2004-04-19 | 2013-01-29 | The Invention Science Fund I, Llc | Telescoping perfusion management system |
US8353896B2 (en) | 2004-04-19 | 2013-01-15 | The Invention Science Fund I, Llc | Controllable release nasal system |
US9011329B2 (en) | 2004-04-19 | 2015-04-21 | Searete Llc | Lumenally-active device |
US8092549B2 (en) | 2004-09-24 | 2012-01-10 | The Invention Science Fund I, Llc | Ciliated stent-like-system |
AU2005244734A1 (en) | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR MANUFACTURING A DEVICE FOR SAMPLING LIQUIDS |
WO2005123173A1 (en) * | 2004-06-10 | 2005-12-29 | 3M Innovative Properties Company | Patch application device and kit |
US20060030811A1 (en) * | 2004-08-03 | 2006-02-09 | Wong Patrick S | Method and device for enhancing transdermal agent flux |
US8062250B2 (en) | 2004-08-10 | 2011-11-22 | Unomedical A/S | Cannula device |
US20060100584A1 (en) * | 2004-08-10 | 2006-05-11 | Orest Olejnik | Needleless microprotrusion elastoplast system |
US20060058602A1 (en) * | 2004-08-17 | 2006-03-16 | Kwiatkowski Krzysztof C | Interstitial fluid analyzer |
US7316665B2 (en) * | 2004-08-25 | 2008-01-08 | Becton, Dickinson And Company | Method and device for the delivery of a substance including a covering |
KR20070099540A (ko) * | 2004-09-08 | 2007-10-09 | 알자 코포레이션 | 향상된 피부 점착성 및 순응도를 갖는 미세돌출부 어레이 |
AU2005306422A1 (en) | 2004-11-18 | 2006-05-26 | 3M Innovative Properties Company | Low-profile microneedle array applicator |
EP2388078B1 (en) | 2004-11-18 | 2013-03-20 | 3M Innovative Properties Co. | Method of contact coating a microneedle array |
US8057842B2 (en) | 2004-11-18 | 2011-11-15 | 3M Innovative Properties Company | Method of contact coating a microneedle array |
JP4927751B2 (ja) * | 2004-11-18 | 2012-05-09 | スリーエム イノベイティブ プロパティズ カンパニー | マイクロニードルアレイのコーティング方法 |
CN101060882B (zh) | 2004-11-18 | 2010-06-16 | 3M创新有限公司 | 微针阵列施放器和保持器 |
EP2067599B1 (en) | 2004-12-07 | 2016-10-26 | 3M Innovative Properties Company | Method of molding a microneedle |
AU2005313662B2 (en) | 2004-12-10 | 2011-07-14 | Unomedical A/S | Cannula inserter |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
JP2008529750A (ja) * | 2005-02-16 | 2008-08-07 | アルザ コーポレイション | 生体適合性が改善されたマイクロプロジェクションアレイ |
US7985199B2 (en) | 2005-03-17 | 2011-07-26 | Unomedical A/S | Gateway system |
EP1869414A4 (en) | 2005-03-29 | 2010-07-28 | Arkal Medical Inc | DEVICES, SYSTEMS, METHODS, AND TOOLS FOR CONTINUOUS GLUCOSE MONITORING |
US10035008B2 (en) | 2005-04-07 | 2018-07-31 | 3M Innovative Properties Company | System and method for tool feedback sensing |
US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US20080195035A1 (en) | 2005-06-24 | 2008-08-14 | Frederickson Franklyn L | Collapsible Patch and Method of Application |
WO2007002521A2 (en) | 2005-06-27 | 2007-01-04 | 3M Innovative Properties Company | Microneedle array applicator device |
JP2008543528A (ja) * | 2005-06-27 | 2008-12-04 | スリーエム イノベイティブ プロパティズ カンパニー | マイクロニードルカートリッジアセンブリ及び適用方法 |
JP2007014588A (ja) * | 2005-07-08 | 2007-01-25 | Nano Device & System Research Inc | 経皮投与装置,経皮投与装置製造用金型 |
US20070078414A1 (en) * | 2005-08-05 | 2007-04-05 | Mcallister Devin V | Methods and devices for delivering agents across biological barriers |
CA2629393C (en) * | 2005-09-06 | 2014-06-10 | Theraject, Inc. | Solid solution perforator containing drug particle and/or drug-adsorbed particles |
PL1762259T3 (pl) | 2005-09-12 | 2011-03-31 | Unomedical As | Urządzenie wprowadzające, przeznaczone do zestawu infuzyjnego, z pierwszą i drugą jednostką sprężynową |
CN101267896A (zh) * | 2005-09-12 | 2008-09-17 | 阿尔扎公司 | 可涂覆的透皮给药微突起组合件 |
US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
CA2623589C (en) | 2005-09-30 | 2014-07-22 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
US8741260B2 (en) * | 2005-10-07 | 2014-06-03 | Armagen Technologies, Inc. | Fusion proteins for delivery of GDNF to the CNS |
US8124095B2 (en) * | 2005-10-07 | 2012-02-28 | Armagen Technologies, Inc. | Fusion proteins for delivery of erythropoietin to the CNS |
US8053569B2 (en) * | 2005-10-07 | 2011-11-08 | Armagen Technologies, Inc. | Nucleic acids encoding and methods of producing fusion proteins |
CA2629193C (en) * | 2005-11-18 | 2016-03-29 | 3M Innovative Properties Company | Coatable compositions, coatings derived therefrom and microarrays having such coatings |
US20080262416A1 (en) * | 2005-11-18 | 2008-10-23 | Duan Daniel C | Microneedle Arrays and Methods of Preparing Same |
USD655807S1 (en) | 2005-12-09 | 2012-03-13 | Unomedical A/S | Medical device |
WO2007075614A1 (en) * | 2005-12-21 | 2007-07-05 | 3M Innovative Properties Company | Microneedle devices |
WO2007071255A1 (en) | 2005-12-23 | 2007-06-28 | Unomedical A/S | Device for administration |
AU2007219546B8 (en) | 2006-02-28 | 2012-07-05 | Unomedical A/S | Inserter for infusion part and infusion part provided with needle protector |
WO2007106597A2 (en) * | 2006-03-15 | 2007-09-20 | Alza Corporation | Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia |
US8180436B2 (en) | 2006-04-12 | 2012-05-15 | The Invention Science Fund I, Llc | Systems for autofluorescent imaging and target ablation |
US20120035437A1 (en) | 2006-04-12 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Navigation of a lumen traveling device toward a target |
US9119945B2 (en) | 2006-04-20 | 2015-09-01 | 3M Innovative Properties Company | Device for applying a microneedle array |
US20070299388A1 (en) * | 2006-04-25 | 2007-12-27 | Alza Corporation | Microprojection array application with multilayered microprojection member for high drug loading |
US20070293816A1 (en) * | 2006-04-25 | 2007-12-20 | Alza Corporation | Microprojection Array Application with Grouped Microprojections for High Drug Loading |
CN101432040A (zh) * | 2006-04-25 | 2009-05-13 | 阿尔扎公司 | 具有雕刻的微突出物的微突出物阵列用于高的药物负载 |
WO2007140783A2 (en) | 2006-06-07 | 2007-12-13 | Unomedical A/S | Inserter for transcutaneous sensor |
MX2008015247A (es) | 2006-06-09 | 2008-12-15 | Unomedical As | Almohadilla de montaje. |
WO2008014791A1 (en) | 2006-08-02 | 2008-02-07 | Unomedical A/S | Cannula and delivery device |
US7741446B2 (en) | 2006-08-18 | 2010-06-22 | Armagen Technologies, Inc. | Fusion antibodies that cross the blood-brain barrier in both directions |
EP1917990A1 (en) | 2006-10-31 | 2008-05-07 | Unomedical A/S | Infusion set |
WO2008091602A2 (en) * | 2007-01-22 | 2008-07-31 | Corium International, Inc. | Applicators for microneedle arrays |
AU2008241470B2 (en) | 2007-04-16 | 2013-11-07 | Corium Pharma Solutions, Inc. | Solvent-cast microneedle arrays containing active |
US20090011040A1 (en) * | 2007-05-02 | 2009-01-08 | Naash Muna I | Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases |
DK2155311T3 (da) | 2007-06-20 | 2013-02-04 | Unomedical As | Fremgangsmåde og apparat til fremstilling af et kateter |
JP2010531692A (ja) | 2007-07-03 | 2010-09-30 | ウノメディカル アクティーゼルスカブ | 双安定均衡状態を持つ挿入器 |
US8486003B2 (en) | 2007-07-10 | 2013-07-16 | Unomedical A/S | Inserter having two springs |
WO2009010396A1 (en) | 2007-07-18 | 2009-01-22 | Unomedical A/S | Insertion device with pivoting action |
EP2997976A1 (en) * | 2007-07-27 | 2016-03-23 | Armagen Technologies, Inc. | Methods and compositions for increasing alpha-l-iduronidase activity in the cns |
WO2009048607A1 (en) | 2007-10-10 | 2009-04-16 | Corium International, Inc. | Vaccine delivery via microneedle arrays |
JP2011511688A (ja) | 2008-02-13 | 2011-04-14 | ウノメディカル アクティーゼルスカブ | カニューレ部品と流路との間のシール |
EP2259816B1 (en) | 2008-02-20 | 2015-10-21 | Unomedical A/S | Insertion device with horizontally moving part |
US20090259176A1 (en) * | 2008-04-09 | 2009-10-15 | Los Gatos Research, Inc. | Transdermal patch system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
WO2009142741A1 (en) * | 2008-05-21 | 2009-11-26 | Theraject, Inc. | Method of manufacturing solid solution peforator patches and uses thereof |
WO2009145920A1 (en) | 2008-05-30 | 2009-12-03 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
EP3639744B1 (en) | 2008-06-06 | 2021-11-24 | Intuity Medical, Inc. | Blood glucose meter and method of operating |
JP5642066B2 (ja) | 2008-06-06 | 2014-12-17 | インテュイティ メディカル インコーポレイテッド | 体液の試料内に含まれている検体の存在または濃度を決定する検定を行う方法および装置 |
US20100098693A1 (en) * | 2008-10-07 | 2010-04-22 | Pardridge William M | Compositions and methods for blood-brain barrier delivery of organophosphatases |
KR20110127642A (ko) | 2008-12-22 | 2011-11-25 | 우노메디컬 에이/에스 | 접착패드를 구비하는 의료기구 |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9533055B2 (en) | 2009-03-18 | 2017-01-03 | Armagen Technologies, Inc. | Compositions and methods for blood-brain barrier delivery of IgG-decoy receptor fusion proteins |
JP5367598B2 (ja) * | 2009-03-30 | 2013-12-11 | シスメックス株式会社 | 血中濃度−時間曲線下面積を用いた血液中の測定対象成分の濃度変動の推定方法及び装置 |
US20110009782A1 (en) * | 2009-07-07 | 2011-01-13 | Naya Touch, Inc. | Dermal roller with therapeutic microstructures |
RU2012107433A (ru) | 2009-07-30 | 2013-09-10 | Уномедикал А/С | Устройство для введения с горизонтальной движущейся частью |
MX2012000778A (es) | 2009-08-07 | 2012-07-30 | Unomedical As | Dispositivo de suministro con sensor y una o mas canulas. |
US9024766B2 (en) * | 2009-08-28 | 2015-05-05 | The Invention Science Fund, Llc | Beverage containers with detection capability |
US8810417B2 (en) * | 2009-08-28 | 2014-08-19 | The Invention Science Fund I, Llc | Beverage immersate with detection capability |
CN102473276B (zh) | 2009-08-31 | 2016-04-13 | 雅培糖尿病护理公司 | 医疗装置及方法 |
DK2485761T3 (da) | 2009-10-09 | 2019-05-06 | Armagen Inc | Fremgangsmåder og sammensætninger til øgning af iduronat-2-sulfatase-aktivitet i CNS |
EP3461889A1 (en) | 2009-11-19 | 2019-04-03 | Solis Biodyne | Compositions for increasing polypeptide stability and activity, and related methods |
EP2506768B1 (en) | 2009-11-30 | 2016-07-06 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
LT3622883T (lt) | 2010-03-24 | 2021-08-25 | Abbott Diabetes Care, Inc. | Medicinos prietaiso įvedikliai ir medicinos prietaisų įvedimo ir naudojimo būdai |
WO2011121023A1 (en) | 2010-03-30 | 2011-10-06 | Unomedical A/S | Medical device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
RU2569029C2 (ru) | 2010-05-04 | 2015-11-20 | Кориум Интернэшнл, Инк. | Аппликаторы для микроигл |
AU2011248108B2 (en) | 2010-05-04 | 2016-05-26 | Corium Pharma Solutions, Inc. | Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
WO2011162823A1 (en) | 2010-06-25 | 2011-12-29 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
EP2433663A1 (en) | 2010-09-27 | 2012-03-28 | Unomedical A/S | Insertion system |
EP2436412A1 (en) | 2010-10-04 | 2012-04-04 | Unomedical A/S | A sprinkler cannula |
EP3750480B1 (en) | 2011-08-03 | 2022-02-02 | Intuity Medical, Inc. | Body fluid sampling arrangement |
US11197689B2 (en) | 2011-10-05 | 2021-12-14 | Unomedical A/S | Inserter for simultaneous insertion of multiple transcutaneous parts |
EP2583715A1 (en) | 2011-10-19 | 2013-04-24 | Unomedical A/S | Infusion tube system and method for manufacture |
US9440051B2 (en) | 2011-10-27 | 2016-09-13 | Unomedical A/S | Inserter for a multiplicity of subcutaneous parts |
JP6266529B2 (ja) | 2011-12-02 | 2018-01-24 | アーマジェン・インコーポレイテッドArmagen, Inc. | Cnsにおけるアリールスルファターゼa活性を増加するための方法および組成物 |
EP3300658B1 (en) | 2011-12-11 | 2024-01-17 | Abbott Diabetes Care, Inc. | Analyte sensor methods |
KR102265808B1 (ko) | 2012-12-21 | 2021-06-16 | 코리움, 인크. | 치료제의 전달을 위한 마이크로어레이 및 그것의 사용방법 |
JP6487899B2 (ja) | 2013-03-12 | 2019-03-20 | コリウム インターナショナル, インコーポレイテッド | 微小突起アプリケータ |
JP2016514133A (ja) | 2013-03-15 | 2016-05-19 | コリウム インターナショナル, インコーポレイテッド | ポリマーを含まない微細構造物を含むマイクロアレイ、製造方法および使用方法 |
EP4194028A1 (en) | 2013-03-15 | 2023-06-14 | Corium Pharma Solutions, Inc. | Multiple impact microprojection applicators |
AU2014233541B2 (en) | 2013-03-15 | 2018-11-22 | Corium Pharma Solutions, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
MX2015012933A (es) | 2013-03-15 | 2016-09-19 | Corium Int Inc | Micrordenamiento para suministro de agente terapeutico y metodos de uso. |
EP3011544A4 (en) | 2013-06-21 | 2017-02-22 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
US20150023956A1 (en) | 2013-07-22 | 2015-01-22 | Armagen Technologies, Inc. | Methods and compositions for increasing enzyme activity in the cns |
US20150038897A1 (en) | 2013-07-30 | 2015-02-05 | Zosano Pharma, Inc. | Low-Profile Microneedle Patch Applicator |
CN106061546A (zh) * | 2014-02-10 | 2016-10-26 | Lts勒曼治疗系统股份公司 | 微针系统及其制造方法 |
WO2015194260A1 (ja) * | 2014-06-18 | 2015-12-23 | 凸版印刷株式会社 | マイクロニードルユニット |
EP3188714A1 (en) | 2014-09-04 | 2017-07-12 | Corium International, Inc. | Microstructure array, methods of making, and methods of use |
US10538589B2 (en) | 2015-01-14 | 2020-01-21 | Armagen Inc. | Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US10857093B2 (en) | 2015-06-29 | 2020-12-08 | Corium, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
US9918932B2 (en) | 2016-02-19 | 2018-03-20 | Zosano Pharma Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines |
EP3672570A1 (en) | 2017-08-23 | 2020-07-01 | Zosano Pharma Corporation | Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches |
US11660264B2 (en) | 2017-08-23 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
US11660265B2 (en) | 2018-06-28 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
JP2021049141A (ja) | 2019-09-25 | 2021-04-01 | 富士フイルム株式会社 | マイクロニードルアレイ、支持部材、マイクロニードルアレイの製造方法及びマイクロニードルアレイユニット |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE25637E (en) | 1964-09-08 | Means for vaccinating | ||
US2893392A (en) | 1958-01-08 | 1959-07-07 | American Cyanamid Co | Article of manufacture for intracutaneous injections |
US3072122A (en) | 1959-01-15 | 1963-01-08 | Rosenthal Sol Roy | Package for transcutaneous injection |
US3675766A (en) | 1970-02-04 | 1972-07-11 | Sol Roy Rosenthal | Multiple puncture injector device |
US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
BE795384A (fr) | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
US4379454A (en) | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4340048A (en) | 1981-03-28 | 1982-07-20 | Alza Corporation | Self-driven hypodermic injector |
US4753651A (en) | 1982-08-30 | 1988-06-28 | Alza Corporation | Self-driven pump |
US4725439A (en) | 1984-06-29 | 1988-02-16 | Alza Corporation | Transdermal drug delivery device |
US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4655766A (en) | 1985-08-01 | 1987-04-07 | Alza Corporation | Fluid imbibing pump with self-regulating skin patch |
US4756314A (en) | 1985-10-28 | 1988-07-12 | Alza Corporation | Sweat collection patch |
US4698062A (en) | 1985-10-30 | 1987-10-06 | Alza Corporation | Medical device for pulsatile transdermal delivery of biologically active agents |
US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US4832953A (en) | 1987-08-13 | 1989-05-23 | Alza Corporation | Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix |
US5362307A (en) | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
KR970011449B1 (ko) | 1988-01-29 | 1997-07-11 | 더 리전트 오브 디 유니버시티 오브 캘리포니아 | 이온전기 영동형 비침입 검체 채취 또는 이송 장치 및 방법 |
GB2221394B (en) | 1988-08-05 | 1992-03-04 | Eilert Eilertsen | An injection device |
US5438984A (en) | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
US5169382A (en) | 1988-10-03 | 1992-12-08 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5147296A (en) | 1988-10-03 | 1992-09-15 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
EP0429842B1 (en) | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
US5077104A (en) | 1989-12-21 | 1991-12-31 | Alza Corporation | Nicotine packaging materials |
ES2082973T3 (es) | 1990-03-30 | 1996-04-01 | Alza Corp | Dispositivo para administracion iontoforetica de farmacos. |
US5242406A (en) | 1990-10-19 | 1993-09-07 | Sil Medics Ltd. | Liquid delivery device particularly useful for delivering drugs |
PT99344A (pt) | 1990-10-29 | 1993-12-31 | Alza Corp | Dispositivo para aplicacao iontoforetica e metodo para o hidratar |
US5279544A (en) | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
US5312456A (en) | 1991-01-31 | 1994-05-17 | Carnegie Mellon University | Micromechanical barb and method for making the same |
US5310404A (en) | 1992-06-01 | 1994-05-10 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
AU4256496A (en) | 1994-12-09 | 1996-06-26 | Novartis Ag | Transdermal system |
AU5869796A (en) * | 1995-05-22 | 1996-12-11 | Ned A. Godshall | Micromechanical patch for enhancing the delivery of compound s through the skin |
WO1996037155A1 (en) | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical device and method for enhancing delivery of compounds through the skin |
DE19525607A1 (de) | 1995-07-14 | 1997-01-16 | Boehringer Ingelheim Kg | Transcorneales Arzneimittelfreigabesystem |
JP3899427B2 (ja) | 1995-08-29 | 2007-03-28 | アルテア セラピューティクス コーポレイション | 薬物送達および鑑視適用のためのヒト皮膚の微細穿孔 |
ES2195151T3 (es) | 1996-06-18 | 2003-12-01 | Alza Corp | Dispositivo de mejora de aporte o de muestreo de agentes transdermicos. |
KR100453132B1 (ko) * | 1996-12-20 | 2004-10-15 | 앨자 코포레이션 | 경피 약제 플럭스를 향상시키기 위한 장치 및 방법 |
KR100557261B1 (ko) | 1997-12-11 | 2006-03-07 | 알자 코포레이션 | 경피성 작용제 유동률을 증진시키기 위한 장치 |
-
1998
- 1998-12-09 KR KR1020007006273A patent/KR100557261B1/ko not_active IP Right Cessation
- 1998-12-09 ES ES98964712T patent/ES2314995T3/es not_active Expired - Lifetime
- 1998-12-09 CN CNB988119889A patent/CN1206004C/zh not_active Expired - Fee Related
- 1998-12-09 AT AT98964712T patent/ATE406935T1/de not_active IP Right Cessation
- 1998-12-09 PT PT98964712T patent/PT1037687E/pt unknown
- 1998-12-09 DK DK98964712T patent/DK1037687T3/da active
- 1998-12-09 CA CA002313700A patent/CA2313700C/en not_active Expired - Fee Related
- 1998-12-09 US US09/208,813 patent/US6322808B1/en not_active Expired - Lifetime
- 1998-12-09 JP JP2000523970A patent/JP2001525227A/ja active Pending
- 1998-12-09 DE DE69839969T patent/DE69839969D1/de not_active Expired - Lifetime
- 1998-12-09 WO PCT/US1998/026156 patent/WO1999029298A2/en active IP Right Grant
- 1998-12-09 EP EP98964712A patent/EP1037687B8/en not_active Expired - Lifetime
- 1998-12-09 AU AU19974/99A patent/AU757230B2/en not_active Ceased
-
2000
- 2000-10-04 US US09/684,163 patent/US6953589B1/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8932539B2 (en) | 2009-03-25 | 2015-01-13 | Pathway Genomics Corporation | Saliva sample collection systems |
CN103908240A (zh) * | 2014-04-03 | 2014-07-09 | 汪成 | 一种人体电信号监测用电极片 |
CN110063836A (zh) * | 2014-04-23 | 2019-07-30 | 塞罗斯医学有限责任公司 | 真空辅助药物递送装置 |
Also Published As
Publication number | Publication date |
---|---|
ES2314995T3 (es) | 2009-03-16 |
PT1037687E (pt) | 2008-12-17 |
WO1999029298A3 (en) | 1999-08-12 |
CA2313700A1 (en) | 1999-06-17 |
DE69839969D1 (de) | 2008-10-16 |
EP1037687B8 (en) | 2008-10-22 |
WO1999029298A2 (en) | 1999-06-17 |
CA2313700C (en) | 2009-11-24 |
US6953589B1 (en) | 2005-10-11 |
KR20010032929A (ko) | 2001-04-25 |
AU757230B2 (en) | 2003-02-06 |
DK1037687T3 (da) | 2009-01-26 |
AU1997499A (en) | 1999-06-28 |
JP2001525227A (ja) | 2001-12-11 |
KR100557261B1 (ko) | 2006-03-07 |
CN1206004C (zh) | 2005-06-15 |
EP1037687B1 (en) | 2008-09-03 |
US6322808B1 (en) | 2001-11-27 |
EP1037687A2 (en) | 2000-09-27 |
ATE406935T1 (de) | 2008-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1206004C (zh) | 增强透皮物剂流量的装置 | |
CN1170603C (zh) | 增强透皮物剂流量的装置 | |
CN1161164C (zh) | 用于通过体表导入或提取质剂的装置 | |
JP4012252B2 (ja) | 薬剤の経皮放出又はサンプリングを高めるための装置 | |
CN101711130B (zh) | 形成多个微导管的装置 | |
JP4412874B2 (ja) | 薄膜組織インターフェイスデバイスを使用する生物学的膜のミクロポレーションのための装置、およびそのための方法 | |
EP2319578A1 (en) | Transdermal drug delievery patch system, method of making same and method of using same | |
EP1911488A2 (en) | Device for enhancing transdermal agent flux | |
MXPA00005765A (en) | Device for enhancing transdermal agent flux | |
MXPA00005761A (en) | Device for enhancing transdermal agent flux | |
KR20000016696A (ko) | 경피 제제 투여 또는 샘플링을 향상시키기 위한 장치 | |
MXPA00005725A (es) | Dispositivo para aumentar el flujo transdermico de agentes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050615 Termination date: 20111209 |